ArticleBMC pulmonary medicine2026
Clinical efficacy and cost-effectiveness of mepolizumab for COPD with type 2 inflammation.
Jefferson Antonio Buendía et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it